The laboratory of GRU Cancer Center’s Dr. Chunhong Yan is interested in the molecular mechanism behind the development of prostate cancer. Prostate cancer is associated with aging – not only the genetic alterations induced by the aging process, but...
It has long been established that genetic alterations leading to down-regulated expression of the tumor suppressor protein Pten characterize a major subtype of prostate cancer. As reported recently in Oncogene, the laboratory of GRU Cancer Center’s...
Led by Dr. Chunhong Yan, Cancer Center researchers Drs. Liwei Lang and Han-Fei Ding and their colleagues have generated a novel strategy for identifying compounds that may be further developed as anti-cancer therapeutics. Since overexpression of...